Bank of New York Mellon
STLN

Bank of New York Mellon’s Starling Oncology, Inc. Common Stock STLN Stock Holding History

Bank of New York Mellon’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$961K Buy
176,949
+14,507
+9% +$60.9K ﹤0.01% 3384
2026
Q1 		$499K Buy
162,442
+23,604
+17% +$72.4K ﹤0.01% 3605
2025
Q4 		$494K Buy
138,838
+6,941
+5% +$25.7K ﹤0.01% 3624
2025
Q3 		$460K Sell
131,897
-116,749
-47% -$400K ﹤0.01% 3651
2025
Q2 		$510K Buy
248,646
+123,505
+99% +$309K ﹤0.01% 3496
2025
Q1 		$143K Hold
125,141
– – ﹤0.01% 3957
2024
Q4 		$38.7K Hold
125,141
– – ﹤0.01% 4089
2024
Q3 		$40.9K Buy
125,141
+80,073
+178% +$33.2K ﹤0.01% 4053
2024
Q2 		$20.7K Hold
45,068
– – ﹤0.01% 4081
2024
Q1 		$71.2K Sell
45,068
-3,651
-7% -$6.94K ﹤0.01% 4062
2023
Q4 		$99.4K Buy
+48,719
New +$84.5K ﹤0.01% 4084
2023
Q2 		– Sell
-93,656
Closed -$63.5K – 4456
2023
Q1 		$63.5K Sell
93,656
-2,270
-2% -$2.9K ﹤0.01% 4149
2022
Q4 		$158K Buy
95,926
+9,414
+11% +$26.4K ﹤0.01% 4036
2022
Q3 		$401K Buy
86,512
+49,057
+131% +$288K ﹤0.01% 3694
2022
Q2 		$190K Buy
+37,455
New +$273K ﹤0.01% 4076

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $281M AUM 36.14% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM

Bank of New York Mellon's STLN Position: Q2 2026 in Review

Bank of New York Mellon increased its Starling Oncology, Inc. Common Stock (STLN) stake by 8.9% in Q2 2026, buying an estimated $60.9K and bringing the position to 176,949 shares worth $961K. The position accounts for ﹤0.01% of the portfolio, ranked #3384.

Bank of New York Mellon first reported a position in STLN in Q2 2022 and has held it in 15 quarters since. 40 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Bank of New York Mellon held 176,949 shares of Starling Oncology, Inc. Common Stock worth $961K as of Q2 2026.
  • Bank of New York Mellon bought 14,507 Starling Oncology, Inc. Common Stock shares in Q2 2026, an estimated $60.9K.
  • Starling Oncology, Inc. Common Stock made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3384 holding.
  • Bank of New York Mellon first reported a position in Starling Oncology, Inc. Common Stock in Q2 2022 and has held it in 15 quarters since.
  • 40 funds tracked by Wall St. Rank held Starling Oncology, Inc. Common Stock as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.